Clinical Trial Update: Study to Evaluate the Safety, Tolerability, and Efficacy of PEP-TISSEEL in Subjects With Chronic Radiation Ulcer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on a Phase 1/2 study evaluating PEP-TISSEEL for chronic radiation ulcer; status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Radiation Ulcer

Drugs mentioned

• PEP-TISSEEL

Snippet

Sponsor: Rion Inc. | Conditions: Chronic Radiation Ulcer | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING